Julia Grapsa, Fabien Praz, Paul Sorajja, Joao L Cavalcante, Marta Sitges, Maurizio Taramasso, Nicolo Piazza, David Messika Zeitoun, Hector I Michelena, Nadira Hamid, Julien Dreyfus, Giovanni Benfari, Edgar Argulian, Alaide Chieffo, Didier Tchetche, Lawrence Rudski, Jeroen J Bax, Stephan Von Bardeleben, Tiffany Patterson, Simon Redwood, Vinayak N Bapat, Georg Nickenig, Philipp Lurz, Jörg Hausleiter, Susheel Kodali, Rebecca T Hahn, Francesco Maisano, Maurice Enriquez Sarano
Tricuspid regurgitation (TR) is a highly prevalent and heterogeneous valvular disease, independently associated with excess mortality and high morbidity in all clinical contexts. TR is profoundly undertreated by surgery and is often discovered late in patients presenting with right-sided heart failure. To address the issue of undertreatment and poor clinical outcomes without intervention, numerous structural tricuspid interventional devices have been and are in development, a challenging process due to the unique anatomic and physiologic characteristics of the tricuspid valve, and warranting well-designed clinical trials...
September 13, 2023: JACC. Cardiovascular Imaging